Y-27632
Y-27632 DIHYDROCHLORIDE;ROCK INHIBITOR;(R)-(+)-TRANS-N-(4-PYRIDYL)-4-(1-AMINOETHYL)-CYCLOHEXANECARBOXAMIDE 2HCL;(R)-(+)-TRANS-4-(1-AMINOETHYL)-N-(4-PYRIDYL)CYCLOHEXANECARBOXAMIDE DIHYDROCHLORIDE;(+)-R-TRANS-4-(AMINOETHYL)-N-(4-PYRIDYL)-CYCLOHEXANECARBOXAMIDE 2HCL H2O;TRANS-4-[(1R)-1-AMINOETHYL]-N-4-PYRIDINYLCYCLOHEXANECARBOXAMIDE DIHYDROCHLORIDE;Y-276322HCl;Cyclohexanecarboxamide, 4-[(1R)-1-aminoethyl]-N-4-pyridinyl-, trans-;Y27632;Y-27632;4-[(1R)-1-aminoethyl]-N-pyridin-4-ylcyclohexane-1-carboxamide;Y-27632-dihydrochloride;4-[(1R)-1-Aminoethyl]-N-pyridin-4-ylcyclohexane-1-carboxamide dihydrochloride;Y-27632, free base;4-[(1R)-1-Aminoethyl]-N-(4-pyridinyl)cyclohexanecarboxamide;Y-27632/Y27632;Y-27632 (2HCl),98%;Y-27632, Free Base, >99%;J-525164;KBio3_001027;Bio1_000737;CAS_146986-50-7;NCGC00092276-03;NCGC00092276-02;trans-4-[(1R)-1-aminoethyl]-N-(pyridin-4-yl)cyclohexanecarboxamide;BiomolKI2_000075;NS00073644;SMP2_000199;Y-27632 dihydrochloride;cyclohexanecarboxamide, 4-[(1R)-1-aminoethyl]-N-4-pyridinyl-, trans-;AKOS028109253;Ximelegatran;HMS1362N15;CHEBI:75393;(R)-(+)-trans-N-(4-pyridyl)-4-(1-aminoethyl)-cyclohexanecarboxamide;BiomolKI_000071;2gnf;HMS1792N15;AS-77772;CHEMBL559147;CYCLOHEXANECARBOXAMIDE, 4-((1R)-1-AMINOETHYL)-N-4-PYRIDINYL-, TRANS-;J-008296;CYCLOHEXANECARBOXAMIDE, 4-(1-AMINOETHYL)-N-4-PYRIDINYL-, (4(R)-TRANS)-;4-[(1R)-1-aminoethyl]-N-(4-pyridyl)cyclohexanecarboxamide;NCGC00092276-06;NCGC00092276-04;(R)-TRANS-4-(1-AMINOETHYL)-N-(4-PYRIDYL) CYCLOHEXANECARBOXAMIDE;BDBM50319631;NCGC00387412-04;NCGC00092276-05;BDBM14029;Q6584634;BRD-K44084986-001-03-9;GTPL5290;2gnj;KBio2_000574;s6390;Bio1_001226;KBio3_001028;BSPBio_001234;Bio1_000248;(R)-(+)-trans-4-(1-Aminoethyl)-N-(4-Pyridyl)cyclohexanecarboxamide;(R)-4-(1-Aminoethyl)-N-(pyridin-4-yl)cyclohexanecarboxamide;NSC-751297;Y-27632DIHYDROCHLORIDE;SCHEMBL1980406;(R)-Trans-4-(1-Aminoethyl)-N-(4-Pyridyl)cyclohexanecarboxamide;HMS3403N15;146986-50-7;4-[(1R)-1-aminoethyl]-N-(pyridin-4-yl)cyclohexane-1-carboxamide;CHEBI:92773;CHEMBL1083134;4.BETA.-((1R)-1-AMINOETHYL)-N-(4-PYRIDINYL)CYCLOHEXANE-1.ALPHA.-CARBOXAMIDE;NCGC00092276-08;HMS1990N15;(+)-(r)-trans-4-(1-aminoethyl)-n-(4-pyridyl)cyclohexanecarboxamide;SCHEMBL13970844;SCHEMBL7804373;A25646;KBio2_003142;Y 27632 [WHO-DD];SCHEMBL598993;KBio2_005710;NCGC00092276-07;DB08756;(1R,4r)-4-((R)-1-aminoethyl)-N-(pyridin-4-yl)cyclohexane-1-carboxamide;NCGC00092276-09;Y27;KBioSS_000574;BCPP000008;[+]-[R]-trans-4-[1-aminoethyl]-N-[4-pyridyl]cyclohexanecarboxamide;Bio2_000457;HY-10071;ROCK Inhibitor, Y-27632;(1R,4r)-4-[(1R)-1-aminoethyl]-N-(pyridin-4-yl)cyclohexane-1-carboxamide;UNII-0X370ROP6H;trans-4-[(1R)-1-aminoethyl]-N-pyridin-4-ylcyclohexanecarboxamide;J888.082D;trans-4-((R)-1-Aminoethyl)-N-(pyridin-4-yl)cyclohexanecarboxamide;SCHEMBL18935698;NSC751297;IDI1_002212;1q8t;trans-4-[(1R)-1-Aminoethyl]-N-4-pyridinylcyclohexanecar boxamide ...